• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KOD

KOD

Kodiak Sciences Inc.

NASDAQHealthcareBiotechnologyUS

USD33.87

+0.66 (+1.97%)

Rating:C-

Company Profile

CEO

Victor Perlroth

IPO Date

2018-10-04

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$33.91

Prev. Close

$33.22

Day Low

$32.64

Day High

$35.32

52W Low

$3.43

52W High

$47.84

Market Cap

$1.79B

Volume

0.93M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

30.7%

Avg Negative

21.4%

Avg Neutral

47.8%

News Feed

Kodiak Sciences Has Declined $125M Funding From Baker Bros Citing Strong Balance Sheet

Benzinga·7/23/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Kodiak Sciences Inc. - KOD

PRNewsWire·5/18/2021·↓ negative

Kodiak Sciences (KOD) Q1 Earnings Miss, KSI-301 in Focus

Zacks Investment Research·5/11/2021·↓ negative

Why Kodiak Sciences Stock Is Tumbling Today

The Motley Fool·5/10/2021·↑ positive

Kodiak Sciences Announces First Quarter 2021 Financial Results and Recent Business Highlights

PRNewsWire·5/10/2021·↑ positive

What Makes Kodiak Sciences Inc. (KOD) a New Buy Stock

Zacks Investment Research·5/4/2021·↑ positive

Kodiak Sciences to Present at Upcoming Conferences

PRNewsWire·4/21/2021·↑ positive

Kodiak Sciences Offers Multiple Shots On Goal For Eye Treatments, Multiple Catalysts Expected In 2022

Seeking Alpha·3/15/2021·↑ positive

Kodiak Sciences (KOD) Misses on Q4 Earnings, KSI-301 in Focus

Zacks Investment Research·3/2/2021·↑ positive

Kodiak Sciences Announces Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

PRNewsWire·3/1/2021·↓ negative